SynthesisObesity surgery2025
Incidental GIST in Patients Undergoing Bariatric Surgery: A Systematic Review of Incidence and Management.
Synthesis in Obesity surgery, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- Comparison of laparoscopic versus open approach surgery for gastric gastrointestinal stromal tumors in unfavorable surgical locations.BMC cancer · 2026Article
- Preoperative Upper Endoscopy and Surgical Specimen Findings in Bariatric Surgery Patients.Obesity surgery · 2025Article
- Neglecting Evidence and Systematic Review Protocols While Oversimplifying Management: A Critical Appraisal of Incidental GISTs in Patients Undergoing Bariatric Surgery.Obesity surgery · 2025Article
- Laparoscopic Sleeve Gastrectomy for an Obese Patient with Retroperitoneal Schwannoma: A Case Report.Surgical case reports · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThere has been a rapid increase in prevalence of obesity, and bariatric surgery is the most effective treatment to reduce all-cause mortality. Gastrointestinal stromal tumors (GISTs) comprise approximately 1% of GI tumors and are the most commonly encountered incidental tumor at the time of bariatric surgery. They have a reported prevalence of approximately 0.5%; however, there are no established guidelines for incidental GISTs.
methodsThis study performed a systematic literature search using PubMed to identify 100 articles from 2005 to 2023 on incidental GIST tumors found during bariatric operations.
resultsTotal prevalence of GISTs was 0.54% with an average size of 7.04 mm. Management of these lesions should prioritize negative margins with the least invasive resection. Tumors able to be resected without alteration to bariatric surgery should be managed with a complete wedge resection prioritizing negative margins. In tumors where resection requires alteration to bariatric surgical plan, the decision to proceed with resection and alteration of bariatric surgical plan should be made only if previous discussions have been made with patient. Lastly, if resection of the GIST precludes the ability to perform the bariatric procedure, consideration to resect the GIST with the goal of negative margins should be prioritized with a plan to discuss future bariatric procedures after.
conclusionThe goal of this paper is to remind bariatric surgeons to be aware of GISTs and provide the possible approaches to management.
Indexed as
Identifiers
39904834What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.